Literature DB >> 19588915

Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.

Leela Pandi1, Justin M Kollman, Francisco Lopez-Lira, Jason M Burrows, Marcia Riley, Russell F Doolittle.   

Abstract

When fibrin clots are formed in vitro in the presence of certain positively charged peptides, the turbidity is enhanced and fibrinolysis is delayed. Here we show that these two phenomena are not always linked and that different families of peptides bring about the delay of lysis in different ways. In the case of intrinsically adhesive peptides corresponding to certain regions of the fibrinogen gammaC and betaC domains, even though these peptides bind to fibrin(ogen) and enhance turbidity, the delay in lysis is mainly due to direct inhibition of plasminogen activation. In contrast, for certain pentapeptides patterned on fibrin B knobs, the delay in lysis is a consequence of how fibrin units assemble. On their own, these B knob surrogates can induce the gelation of fibrinogen molecules. The likely cause of enhanced clot turbidity and delay in fibrinolysis was revealed by a crystal structure of the D-dimer from human fibrinogen cocrystallized with GHRPYam, the packing of which showed the direct involvement of the ligand tyrosines in antiparallel betaC-betaC interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19588915     DOI: 10.1021/bi900647g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Engineering fibrin polymers through engagement of alternative polymerization mechanisms.

Authors:  Sarah E Stabenfeldt; Merek Gourley; Laxminarayanan Krishnan; James B Hoying; Thomas H Barker
Journal:  Biomaterials       Date:  2011-10-21       Impact factor: 12.479

2.  Exposure of the lysine in the gamma chain dodecapeptide of human fibrinogen is not enhanced by adsorption to poly(ethylene terephthalate) as measured by biotinylation and mass spectrometry.

Authors:  Vitaliy Ovod; Evan A Scott; Megan M Flake; Stanley R Parker; Randall J Bateman; Donald L Elbert
Journal:  J Biomed Mater Res A       Date:  2011-12-30       Impact factor: 4.396

Review 3.  Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level.

Authors:  Ashley C Brown; Thomas H Barker
Journal:  Acta Biomater       Date:  2013-09-19       Impact factor: 8.947

Review 4.  Fibrinolysis and the control of blood coagulation.

Authors:  John C Chapin; Katherine A Hajjar
Journal:  Blood Rev       Date:  2014-09-16       Impact factor: 8.250

5.  Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.

Authors:  Daria Zamolodchikov; Sidney Strickland
Journal:  Blood       Date:  2012-01-11       Impact factor: 22.113

6.  The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.

Authors:  Colin Longstaff; Craig Thelwell; Stella C Williams; Marta M C G Silva; László Szabó; Krasimir Kolev
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

Review 7.  Molecular mechanisms affecting fibrin structure and stability.

Authors:  Susan T Lord
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

8.  Modulation of fibrin matrix properties via knob:hole affinity interactions using peptide-PEG conjugates.

Authors:  Allyson S C Soon; Christine S Lee; Thomas H Barker
Journal:  Biomaterials       Date:  2011-03-23       Impact factor: 12.479

9.  Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

Authors:  Robert A Campbell; Katherine A Overmyer; Craig H Selzman; Brett C Sheridan; Alisa S Wolberg
Journal:  Blood       Date:  2009-10-01       Impact factor: 22.113

10.  Molecular interference of fibrin's divalent polymerization mechanism enables modulation of multiscale material properties.

Authors:  Ashley C Brown; Stephen R Baker; Alison M Douglas; Mark Keating; Martha B Alvarez-Elizondo; Elliot L Botvinick; Martin Guthold; Thomas H Barker
Journal:  Biomaterials       Date:  2015-02-11       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.